Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6

Y. Li; Steven H. Liang

doi:10.1021/acsmedchemlett.6c00096

March 3, 2026ACS Medicinal Chemistry Letters

Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6

View at Publisher

Ask AI

Bookmark

Share

Key Points

To synthesize and assess new inverse agonists designed to target G protein-coupled receptor 6 (GPR6).
Synthesis of pyridopyrazine analogs
Characterization of chemical properties
Assessment of biological activity through assays
Identification of new inverse agonists with potential therapeutic effects
Quantitative measures of biological activity demonstrating efficacy

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This patent highlights the synthesis of new inverse agonists targeting G protein-coupled receptor 6, suggesting potential therapeutic applications.

Abstract

This patent highlight describes the synthesis and assessment of a series of new inverse agonists targeting G protein-coupled receptor 6 (GPR6) based on pyridopyrazine analogs. It details their chemical synthesis, characterization, and biological activity assays.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/69a91d6dd6127c7a504c038f https://doi.org/10.1021/acsmedchemlett.6c00096

View at Publisher

Ask AI

Bookmark

Share

Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading